Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-23
1995-04-25
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
054099480
ABSTRACT:
An improved method of cholinomimetic therapy for cognitive impairments associated with aging and Alzheimer's disease comprising treating a patient with an effective amount of phenserine or a pharmaceutically acceptable salt and derivatives.
REFERENCES:
patent: 4791107 (1988-12-01), Hamer et al.
patent: 4914102 (1990-04-01), Glamkowski
patent: 4971992 (1990-11-01), Glamkowski et al.
patent: 4996201 (1991-02-01), Bergmeier et al.
patent: 5077289 (1991-12-01), Glamkowski et al.
patent: 5081117 (1992-01-01), Glamkowski et al.
patent: 5089267 (1992-02-01), Hille et al.
patent: 5171750 (1992-12-01), Brossi et al.
M. Marta et al., "New Analogs of Physostigmine: Alternative Drugs for Alzheimer's Disease?", Life Science, vol. 43, No. 23, 1988, pp. 1921-1928.
Yu et al, "Carbamate Analogues of (-)-physostigmine: In Vitro Inhibition of Acetyl- and Butyrylcholinesterase", FEBS Letters vol. 234, No. 1, pp. 127-130, Jul., 1988.
Atack et al, "Comparative Inhibitory Effects of Various Physostigmine Analogs Against Acetyl- and Butyrylcholinsterases", Jour. of Pharmacology and Experimental Therapeutics, vol. 249:1, pp. 194-202, 1989.
Brossi Arnold
Greig Nigel H.
Holloway Harold W.
Iijima Setsu
Ingram Donald K.
Henley III Raymond
Jarvis William R. A.
The United States of America as represented by the Secretary of
LandOfFree
Method for treating cognitive disorders with phenserine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating cognitive disorders with phenserine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating cognitive disorders with phenserine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1568127